Zydus Cadila has received the tentative approval from the USFDA to market Deferasirox Tablets, 90 mg, 180 mg, and 360 mg (US RLD — Exjade Tablets). It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.
It is used to treat ongoing high le...read more